Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $85,560 | 87 | 56.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $25,485 | 22 | 16.8% |
| Food and Beverage | $22,016 | 850 | 14.5% |
| Consulting Fee | $9,170 | 10 | 6.1% |
| Travel and Lodging | $7,748 | 36 | 5.1% |
| Honoraria | $1,160 | 3 | 0.8% |
| Education | $205.85 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $60,902 | 221 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $19,470 | 45 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13,336 | 80 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $13,184 | 38 | $0 (2024) |
| Janssen Biotech, Inc. | $9,728 | 314 | $0 (2024) |
| Gilead Sciences, Inc. | $9,592 | 21 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $7,717 | 13 | $0 (2024) |
| Celgene Corporation | $3,431 | 43 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $3,147 | 23 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $2,116 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49,980 | 357 | Phathom Pharmaceuticals, Inc. ($13,184) |
| 2023 | $42,042 | 291 | ABBVIE INC. ($16,743) |
| 2022 | $42,760 | 283 | ABBVIE INC. ($20,469) |
| 2021 | $16,562 | 84 | AbbVie Inc. ($12,911) |
All Payment Transactions
1,015 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Immunology | ||||||
| 12/20/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $74.99 | General |
| Category: Immunology | ||||||
| 12/20/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| 12/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,913.00 | General |
| Category: Immunology | ||||||
| 12/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: Immunology | ||||||
| 12/13/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.87 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $820.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $110.20 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: Gastroenterology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.96 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $123.08 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 287 | 360 | $79,050 | $26,275 |
| 2022 | 3 | 283 | 372 | $79,210 | $27,197 |
| 2021 | 4 | 290 | 342 | $65,125 | $25,642 |
| 2020 | 7 | 318 | 360 | $61,804 | $20,819 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 216 | 289 | $62,135 | $21,111 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $8,525 | $2,815 | 33.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $4,250 | $1,437 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 23 | $4,140 | $912.38 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 201 | 289 | $60,395 | $20,682 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $11,825 | $4,315 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 40 | $6,990 | $2,201 | 31.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 180 | 230 | $40,250 | $17,041 | 42.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 45 | 45 | $12,375 | $4,911 | 39.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 51 | 53 | $7,950 | $2,096 | 26.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 14 | $4,550 | $1,594 | 35.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 110 | 126 | $21,899 | $7,683 | 35.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 106 | 123 | $18,450 | $5,404 | 29.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 18 | 18 | $4,950 | $1,652 | 33.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 28 | 28 | $5,600 | $1,568 | 28.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 13 | $4,135 | $1,553 | 37.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 16 | 21 | $3,360 | $1,517 | 45.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 27 | 31 | $3,410 | $1,443 | 42.3% |
About Mary Ciechoski, ANP
Mary Ciechoski, ANP is a Adult Health healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740245992.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mary Ciechoski, ANP has received a total of $151,344 in payments from pharmaceutical and medical device companies, with $49,980 received in 2024. These payments were reported across 1,015 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($85,560).
As a Medicare-enrolled provider, Ciechoski has provided services to 1,178 Medicare beneficiaries, totaling 1,434 services with total Medicare billing of $99,934. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Location Buffalo, NY
- Active Since 04/19/2006
- Last Updated 10/24/2019
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1740245992
Products in Payments
- RINVOQ (Biological) $20,492
- OCALIVA (Drug) $19,470
- SKYRIZI (Biological) $15,200
- VOQUEZNA (Drug) $13,184
- ZEPOSIA (Drug) $9,816
- Epclusa (Drug) $8,447
- TREMFYA (Drug) $8,037
- CREON (Drug) $7,325
- HUMIRA (Biological) $6,439
- XIFAXAN (Drug) $5,966
- TRULANCE (Drug) $5,940
- STELARA (Biological) $3,807
- Linzess (Drug) $3,147
- ENTYVIO (Biological) $1,907
- RELISTOR (Drug) $1,431
- LINZESS (Drug) $1,071
- IBSRELA (Drug) $777.31
- DUPIXENT (Biological) $535.74
- OMVOH (Drug) $340.46
- SUCRAID (Drug) $308.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Buffalo
Dr. Rosemary Hansen, Dnp, DNP
Adult Health — Payments: $17,105
Susan Demarco, Np, NP
Adult Health — Payments: $14,187
Marcus Sikorski, Np, NP
Adult Health — Payments: $6,467
Melanie Herbert, Np, NP
Adult Health — Payments: $5,994
Jennifer Jaroslawsky, Np, NP
Adult Health — Payments: $5,666
Margaret Spadinger, Np, NP
Adult Health — Payments: $4,175